UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016048
Receipt number R000018652
Scientific Title Evaluation of intravenous regional block with low- dose infliximab for patients with Complex Regional Pain Syndrome
Date of disclosure of the study information 2015/01/05
Last modified on 2014/12/24 16:24:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of intravenous regional block with low- dose infliximab for patients with Complex Regional Pain Syndrome

Acronym

Evaluation of intravenous regional block with low- dose IFX for patients with CRPS

Scientific Title

Evaluation of intravenous regional block with low- dose infliximab for patients with Complex Regional Pain Syndrome

Scientific Title:Acronym

Evaluation of intravenous regional block with low- dose IFX for patients with CRPS

Region

Japan


Condition

Condition

Patients with Complex Regional Pain Syndrome

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the effect of intravenous regional block with low- dose infliximab for patients with Complex Regional Pain Syndrome

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain intensity

Key secondary outcomes

1 Edema
2 Serum concentration of TNF-alpha
3 Allodynia
4 Skin color change
5 Skin temperature change


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intravenous regional sympathetic nerve block with low-dose infliximab

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. In-patient aged over 20 years old of Department Anesthesiology in Fukuoka University Hospital
2. Patients meet the diagnostic criteria for CRPS proposed by a working group in Ministry of Health, Labour, and Welfare.
3. Edema of diseased limb
4. Patients have unilateral diseased limb.
5. Patients meet all screening criteria for tuberculosis.
No past history of latent or active tuberculosis
No sign and symptom of active tuberculosis
Negative results of T-spot or TB skin test
No sign of active or old tuberculosis on Chest X-ray
6. Patients meet screening criteria for hepatitis.
Negative HCV antibody, HBs antigen or HBc antibody test
(HBV DNA not detected).

Key exclusion criteria

1. The following laboratory data
Hb<8.5g/microliter
WBC<3.5*1000cells/microliter Neutrophil<1.0*1000cells/microliter
PLT<5*10000cells/microliter
ALT or AST>1.5*ULN
Total Bilirubin>ULN
Cr>=2.0mg/dL
(NT-pro BNP>=125pg/ml)
2. Patients have severe, progressive or uncontrolled kidney disease, liver disease, skin disease, blood disease, digestive disease, endocrine disease, lung disease, cardiac disease, or neurological disease.
3. Patients had been hospitalized within 3 months for cardiac event(myocardial infarction or unstable angina), stroke or TIA.
4. Patients had severe infection within 2 months.
5. Patients have congestive heart failure in NYHA class 2 to 4.
6. Patients had relapse or progressive infectious disease including chronic renal infection, chronic chest infectious disease or urinary tract infection.
Patients have past history of open drainage wound or ulcer.
7. Abnormal finding of interstitial pneumonia, tuberculosis, or other diseases on chest X-ray within 3 months
8. Past history of demyelinating disease including multiple sclerosis or optic neuritis
9. Patients have past history of gastrointestinal perforation or have active diverticulitis.
10. Patients had non-tuberculous mycobacterial infection or opportunistic infection within 6 months.
11. Hepatitis C positive
12. Hepatitis B positive
13. Patients have malignant neoplasm or had it within 5 years
14. Pregnant or lactating mother
15. Patients have steroid medication.
16. Investigator considers that the enrollment in this study is not benefit for the patient or intravenous regional sympathetic nerve blocking is impossible for the patient.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shiho Shibata

Organization

Fukuoka University Hospital

Division name

Department of Anesthesiology

Zip code


Address

7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan

TEL

092-801-1011

Email

shibatas@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shiho Shibata

Organization

Fukuoka University Hospital

Division name

Department of Anesthesiology

Zip code


Address

7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan

TEL

092-801-1011

Homepage URL


Email

shibatas@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2014 Year 11 Month 27 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 12 Month 24 Day

Last modified on

2014 Year 12 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018652


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name